This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08422/identifier/pubchem-compound/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08422/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08422/identifier/drugbank/
n4http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08422/identifier/pdb/

Statements

Subject Item
n2:DB08422
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB08422 n7:DB08422
dcterms:title
[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE
adms:identifier
n9:PPX n10:23586040 n11:DB08422 n12:99444893
n5:IUPAC-Name
n6:271B5684-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B568A-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5689-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5686-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5687-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5688-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5682-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5680-363D-11E5-9242-09173F13E4C5 n6:271B5683-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5681-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5690-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5691-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B568B-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B568C-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B568E-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B568D-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B568F-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5696-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5698-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5699-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5695-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5694-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5697-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5685-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5692-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5693-363D-11E5-9242-09173F13E4C5